Program

ID and password are required to view and download Program & Abstracts.
After you complete the registration, the secretariat will inform you of the ID and password.

Scientific Program (Updated on 17 February 2022)

Mail Hall, Kitakyushu International Conference Center

Saturday, 2 April 2022

Opening Address

9:00–9:10

Yoshiya Tanaka, President of the 1st International Symposium of Clinical Immunology

Morning Education Lecture 1

Symposium 1

10:10–12:10

Recent progress in Systemic lupus erythematosus

Moderated by

Yoshiya Tanaka (University of Occupational and Environmental Health, Japan)
Hideto Kameda (Toho University, Japan)

S1-1.: Considerations of patient heterogeneity and precision medicine
Betty Diamond (Feinstein Institute of Medical Research, USA)
S1-2.: SLE guideline by JCR/MHLW in Japan
Tatsuya Atsumi (Hokkaido University, Japan)
S1-3.: Novel therapies for lupus nephritis
Chi Chiu Mok (Tuen Mun Hospital, Hong Kong SAR, China)
S1-4.: Biologics for Systemic Lupus Erythematosus
Richard Furie (Northwell Health, USA)

Lunch Time Education Lecture 1

Sponsored by Takeda Pharmaceutical Company Limited

12:20–13:20

LEL1. Overview of Pathogenesis of IBD: Implications for Therapy

Stefan Schreiber (Kiel University, Germany)
Moderated by Takanori Kanai (Keio University, Japan)

Symposium 2

13:30–16:30

Molecular targeted therapies in multiple autoimmune diseases

Moderated by

Yoshiya Tanaka (University of Occupational and Environmental Health, Japan)
Tatsuya Atsumi (Hokkaido University, Japan)

S2-1.: Molecular targeted therapies in rheumatoid arthritis
Hideto Kameda (Toho University, Japan)
S2-2.: Systemic lupus erythematosus
Eric Morand (Monash University, Australia)
S2-3.: B Cell-Targeted Therapy in Scleroderma
Shinichi Sato (The University of Tokyo, Japan)
S2-4.: Molecular targeted therapy in autoimmune neurological disorders
Takashi Kanda (Yamaguchi University, Japan)
S2-5.: Molecular targeted therapy in Ophthalmic diseases
Koh-Hei Sonoda (Kyushu University, Japan)
S2-6.: Molecular Targeted Therapies in Severe Asthma
Hiroshi Nakajima (Chiba University, Japan)
S2-7.: Progress and future perspectives of cancer immunotherapy
Yutaka Kawakami (International University of Health and Welfare, Japan)

Evening Education Lecture 1

Morning Education Lecture 2

Symposium 3

10:00–12:00

Recent progress in Inflammatory bowel diseases

Moderated by Takanori Kanai (Keio University, Japan)

S3-1.: Regenerative medicine and mucosal immunology for IBD
Ryuichi Okamoto (Tokyo Medical and Dental University, Japan)
S3-2.: Single cell analysis to better understand the pathogenesis of IBD
Yohei Mikami (Keio University, Japan)
S3-3.: Role of the interaction between gut microbiota and bile acids in intestinal carcinogenesis
Yuji Naito (Kyoto Prefectural University of Medicine, Japan)
S3-4.: Biologicals in IBD
Hiroshi Nakase (Sapporo Medical University, Japan)

Lunch Time Education Lecture 2

Sponsored by ASAHI KASEI PHARMA CORPORATION

12:10–13:10

LEL2. Perspectives on the Future Treatment of SLE

Richard Furie (Northwell Health, USA)
Moderated by Yoshiya Tanaka (University of Occupational and Environmental Health, Japan)

Closing Address

13:10–13:20